Skip to content

Dr. Aline Nguyen

Active
Private limited companyfounded 2024active for 2 yearsKloosterstraat 120, 2000 Antwerpen, BelgiumKBO/BCE: BE 1008.457.035

From the official registers: KBO 2 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Aline Nguyen has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €86,646 and a net result of €47,551. Its solvency ranks better than 76% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 16-04-2024 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.358.401.085 2000 Antwerpen, since 16-04-2024
Financial year end
31 December
Peppol
Reachable since 19-03-2025

Board and ownership

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€60,719
▲ 25.1%
Turnover
≈ €140,000
estimated
Profit
€47,551
▲ 24.2%
Equity
€86,646
▲ 117%
Total assets
€102,756
▲ 89.0%
Filed on 18-08-2026, 18 days after the deadlineat the National Bank
Score breakdownraises riskFounded in 2024lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.30, cash €98,076Equity €86,646 (84.3% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 85% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+2
equity 84.3% of total assets
Liquidity 96+6
short-term debt 15.7% · cash 95.4%
Profitability 100=
return on assets 46.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 05-2025: 0.3% 06-2025: 0.3%● unchanged vs 05-2025highest value 07-2025: 0.3%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.3 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €8,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 6.3 (3.77 in 2024), above the usual 1.5. Short-term debt is 15.7% and cash 95.4% of total assets. 15.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 85% on liquidity, 80% on profitability and 91% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 6.30, cash €98,076
NBB · annual accounts
lowers risk · Equity €86,646 (84.3% of total assets)
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · 2025 accounts filed 18 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filings
Deviation from the deadline
2025
18 days late
2024
8 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 5 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Comparable companies

These companies have the same main activity as Dr. Aline Nguyen: general medical practice (NACE 86210). They are comparable in size and age: total assets between €98,600 and €115,000, founded between 2023 and 2024.

CompanyTotal assetsGross margin
Dr. Aline Nguyen Antwerpen€102,756€60,719
Maxime De Rop Huisarts Brasschaat€115,169€61,040
Malou Lyssens Willebroek€108,101€65,495
Huisarts Sofie Jacobs Hemiksem€111,125€57,323
Dr Goffette Marine Anderlecht€98,626€59,691
Huisarts Dekock Frederik Vilvoorde€98,754€60,324
Asclepiae Sint-Lambrechts-Woluwe€98,639€60,045
Full comparison

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. Aline Nguyen

What is the company number of Dr. Aline Nguyen?
The company number of Dr. Aline Nguyen is 1008.457.035. The VAT number is the same number with BE in front: BE 1008.457.035.
Where is Dr. Aline Nguyen based?
The registered office is at Kloosterstraat 120, 2000 Antwerpen.Company details
What does Dr. Aline Nguyen do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Aline Nguyen?
The legal form of Dr. Aline Nguyen is Private limited company (BV).
When was Dr. Aline Nguyen founded?
Dr. Aline Nguyen was founded on 16-04-2024.
Is Dr. Aline Nguyen still active?
Yes, Dr. Aline Nguyen is an active enterprise in the KBO register.
What is the turnover of Dr. Aline Nguyen?
The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €60,719 and 32 comparable companies (NACE 862). It probably lies between €110,000 and €180,000.Financials
Is Dr. Aline Nguyen profitable?
In financial year 2025, Dr. Aline Nguyen made a profit of €47,551.
Where can I find the annual accounts of Dr. Aline Nguyen?
Dr. Aline Nguyen filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Aline Nguyen due?
Dr. Aline Nguyen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.